Research Methodologies Followed in This Study:
Primary Research:
Extensive primary research was conducted after acquiring knowledge about the patient blood management market scenario through secondary research. A significant number of primary interviews were conducted with both the demand (healthcare providers, blood bank operators, physicians, and blood bank technicians) and supply sides (developers, manufacturers, and distributors of patient blood management products).
The primaries interviewed for this study include experts from the patient blood management industry (such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering patient blood management products across the globe), purchase managers in healthcare provider organizations, blood banks, blood collection centers, plasma collection centers, and CROs.
Secondary Research:
This research study involved the extensive use of secondary sources, directories, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva), along with government databases, which were used to identify and collect information for this method-based, market-oriented, and commercial study of the market
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131352979
Major Growth Boosters:
The rising prevalence of blood disorders and the increasing number of blood donations & blood donors will fuel market growth over the forecast period. Moreover, the rising prevalence of target diseases and technological advancements in the patient blood management industry will further fuel the growth of the market in the near future.
Expected Growth in Revenue:
The patient blood management market is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024
Market Size Estimation:
A detailed market estimation approach was followed to estimate and validate the size of the patient blood management market and other dependent submarkets, as mentioned above. The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the market.
All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources. All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Blood banks were the key end users in the patient blood management market in 2019
On the basis of end users, the patient blood management market is segmented into hospitals and blood banks. The increasing number of blood donations has increased the need for proper management of blood. Blood banks are the key end users for various blood processing devices, blood collection devices, and blood storage devices. The key factors attributing to the growth of the blood banks segment include the growing awareness about blood donations, rising automation in blood banks, and the increase in the number of blood banks in developing countries.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=131352979
The Asia Pacific region is expected to register significant growth during the forecast period of 2019-2024
The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific blood management market is expected to register significant growth over the forecast period due to the modernization of healthcare infrastructure, increasing prevalence of chronic lifestyle diseases, and rising awareness about blood donation & blood safety. China accounted for a major share of the Asia Pacific market, owing to a large patient pool and favorable government guidelines to improve healthcare infrastructure in the country.
Global Leaders:
The prominent players in the patient blood management market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc.(Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.
An analysis of market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, collaborations, partnerships, agreements, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the patient blood management market.
Read the Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/patient-blood-management-market-131352979.html
Patient Blood Management - Market Penetration Opportunities in Developing Countries
The Business Research Company published its Patient Blood Management Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Patient Blood Management market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the patient blood management market’s segments-1) By Product: Instruments, Accessories, Reagents And Kits, Software2) By Component: Plasma, Whole Blood, Red Blood Cells3) By Application: Hospital, Clinic, Others.View Complete Report: https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-changePatient Blood Management Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.
The entire supply chain has been disrupted, impacting the market negatively.
The market is then expected to recover and reach $12.63 billion in 2023 at a CAGR of 8.28%.HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss.
Patient Blood Management Global Market Report 2021 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography.
It covers the historic period – 2015-2020, and the forecast period – 2021-2025, with additional forecasts for 2025-2030.
The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.TBRC’s market report includes a chapter on the COVID-19 impact on the patient blood management industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it.
With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected patient blood management market growth numbers from 2021-2030.Request a Sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3240=smp The global patient blood management market is expected to grow from $9.97 billion in 2020 to $10.87 billion in 2021 at a compound annual growth rate (CAGR) of 9%.
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
The patient blood management market is expected to reach $14.63 billion in 2025 at a CAGR of 8%.
The global Patient Blood Management Market report offers a comprehensive assessment of the market for the forecast years.
This global industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2026.The key market players for the global Patient Blood Management market are listed below:SpecialityCareHaemonetics CorporationBaden-Wuerttemberg-HessenUPMCB-BRAUNOthersClick here to get a FREE Sample Copy of the Patient Blood Management Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-24326The Global Patient Blood Management Market Report is equipped with market data from 2016 to 2026.
It also evaluates the competitive scenario of the leading players.
The detailed sales channel is also covered in the study.COVID-19 Impact Analysis on Patient Blood Management MarketThe global pandemic COVID-19 has affected the Patient Blood Management market directly or indirectly.
The detailed study highlights the probable outcomes of this global crisis on the Patient Blood Management industry.
The impact study on production, supply-demand, and sales provides a holistic approach to the future.Do You Have Any Query Or Report Customization?
Patient Blood Management Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact – both negative and positive – of COVID-19 on the patient blood management industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
This includes revised market numbers according to the effects of the coronavirus and the expected patient blood management market growth numbers 2021-2030.View Complete Report:https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-changeThe Patient Blood Management Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global patient blood management market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030.
The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.The Patient Blood Management Global Market Report 2021 covers patient blood management market drivers, patient blood management market trends, patient blood management market growth rate, patient blood management market major players, player-adopted strategies in the market, and patient blood management market size.
The global patient blood management market is expected to grow from $9.97 billion in 2020 to $10.87 billion in 2021 at a compound annual growth rate (CAGR) of 9%.
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
The Business Research Company published its Patient Blood Management Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Patient Blood Management market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the patient blood management market’s segments-1) By Product: Instruments, Accessories, Reagents And Kits, Software2) By Component: Plasma, Whole Blood, Red Blood Cells3) By Application: Hospital, Clinic, Others.View Complete Report: https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-changePatient Blood Management Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.
The entire supply chain has been disrupted, impacting the market negatively.
The market is then expected to recover and reach $12.63 billion in 2023 at a CAGR of 8.28%.HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss.
Patient Blood Management Global Market Report 2021 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography.
It covers the historic period – 2015-2020, and the forecast period – 2021-2025, with additional forecasts for 2025-2030.
The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.TBRC’s market report includes a chapter on the COVID-19 impact on the patient blood management industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it.
With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected patient blood management market growth numbers from 2021-2030.Request a Sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3240=smp The global patient blood management market is expected to grow from $9.97 billion in 2020 to $10.87 billion in 2021 at a compound annual growth rate (CAGR) of 9%.
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
The patient blood management market is expected to reach $14.63 billion in 2025 at a CAGR of 8%.
Patient Blood Management Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact – both negative and positive – of COVID-19 on the patient blood management industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
This includes revised market numbers according to the effects of the coronavirus and the expected patient blood management market growth numbers 2021-2030.View Complete Report:https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-changeThe Patient Blood Management Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global patient blood management market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030.
The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.The Patient Blood Management Global Market Report 2021 covers patient blood management market drivers, patient blood management market trends, patient blood management market growth rate, patient blood management market major players, player-adopted strategies in the market, and patient blood management market size.
The global patient blood management market is expected to grow from $9.97 billion in 2020 to $10.87 billion in 2021 at a compound annual growth rate (CAGR) of 9%.
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
The global Patient Blood Management Market report offers a comprehensive assessment of the market for the forecast years.
This global industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2026.The key market players for the global Patient Blood Management market are listed below:SpecialityCareHaemonetics CorporationBaden-Wuerttemberg-HessenUPMCB-BRAUNOthersClick here to get a FREE Sample Copy of the Patient Blood Management Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-24326The Global Patient Blood Management Market Report is equipped with market data from 2016 to 2026.
It also evaluates the competitive scenario of the leading players.
The detailed sales channel is also covered in the study.COVID-19 Impact Analysis on Patient Blood Management MarketThe global pandemic COVID-19 has affected the Patient Blood Management market directly or indirectly.
The detailed study highlights the probable outcomes of this global crisis on the Patient Blood Management industry.
The impact study on production, supply-demand, and sales provides a holistic approach to the future.Do You Have Any Query Or Report Customization?